Pan S.-W.CHIN-CHUNG SHUFeng J.-Y.JUNG-YIEN CHIENJANN-YUAN WANGChan Y.-J.CHONG-JEN YUSu W.-J.2021-05-042021-05-042021-031198743Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/558801Disease progression is a strong indicator of treatment for Mycobacterium avium complex lung disease (MAC-LD). The impact of MAC subspecies on the risk of disease progression remains uncertain in MAC-LD patients.enDisease progression; Mycobacterium aviumcomplex (MAC); Non-tuberculous Mycobacterium(NTM); Prediction; Subspecies identification[SDGs]SDG3azithromycin; clarithromycin; DNA 23S; DNA fragment; internal transcribed spacer; RNA polymerase; aged; antibiotic therapy; Article; atypical mycobacteriosis; bacterium isolate; body mass; cohort analysis; comorbidity; controlled study; coughing; diabetes mellitus; disease course; disease exacerbation; DNA extraction; dyspnea; female; follow up; gene mutation; genotype; hemoptysis; human; incidence; lung infection; major clinical study; male; Mycobacterium avium complex; Mycobacterium chimaera; Mycobacterium intracellulare; nonhuman; polymerase chain reaction; priority journal; retrospective study; sputum smear; subspecies; atypical mycobacteriosis; genetics; lung disease; microbiology; middle aged; Mycobacterium avium complex; pathology; very elderly; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studiesjournal article10.1016/j.cmi.2020.04.020323602072-s2.0-85084847643https://scholars.lib.ntu.edu.tw/handle/123456789/558501